Molecule intelOpportunity: LowerEssential

Tazobactam

38 brands · 27 companies · product forms

ATC: J01CG02

Opportunity snapshot

Launch attractiveness
33
Market saturation
70
Price room
67
Regulatory risk
0
38
brands
27
companies
Rs 814.85
median price
46
price points
3.67x
price spread
100
confidence %

Who competes here

Top companies by brand count — fragmented market (no dominant player) · leader share 5%

Price room

Across observed sources and strengths
CheapestRs 480.3
MedianRs 814.85
Most expensiveRs 1,764.43
Spread3.67×
Sources: DRAP-official, DVAGO, Servaid

max/min price ratio 3.67x across 46 trusted points (Rs 480.3-1764.43). NOTE: mixes strengths (graph prices carry no strength), so treat as indicative.

Brands & products on the market

Sample of 7 live products for Tazobactam — each links to its own medicine page.

Why this score

Launch attractiveness

40% supply-gap(25) + 25% price-variation(67) + 20% low-competition(30) + 15% supply-disruption(0), damped by confidence(100). Higher = more attractive, less crowded opportunity.

Market saturation

27 canonical companies and 38 brands compete (saturation pegged at 30 companies / 150 brands).

Price room

max/min price ratio 3.67x across 46 trusted points (Rs 480.3-1764.43). NOTE: mixes strengths (graph prices carry no strength), so treat as indicative.

Regulatory risk

No DRAP alerts on this molecule's brands.

Confidence

Full coverage.

Packaged brief for this lower opportunity?

Molecule page + company profiles + price-room analysis are the pilot package for pharma teams.

See packaged reports All 3868 molecules

Molecule intelligence as of 2026-07-30. Brand/company counts from DRAP registry and observed retail sources.

For medicine intelligence and professional reference only. Not medical advice.